GlassScriptPhysician profile
Vincent A Viscomi
NPI 1982689493
$27,517.61
in general payments reported to CMS, 2019-2025
30 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $497 · 2021: $554 · 2022: $944 · 2023: $2,940 · 2024: $1,286 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Honoraria: $5,850 · Food and Beverage: $5,276 · Travel and Lodging: $1,770 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,152.00 |
| Honoraria | $5,850.00 |
| Food and Beverage | $5,276.34 |
| Travel and Lodging | $1,769.52 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $13,927.49 | 2019-2025 | Xywav |
| Axsome Therapeutics, INC. | $6,846.51 | 2023-2025 | Sunosi |
| Zoll Respicardia, INC. | $1,446.67 | 2022-2023 | Remede System |
| Inspire Medical Systems, INC. | $1,096.17 | 2019-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $713.35 | 2023-2025 | Lumryz |
| Philips North America LLC | $562.53 | 2019-2025 | (7999) Src Und, Src Undivided |
| Harmony Biosciences LLC | $475.41 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $259.47 | 2019-2023 | Yupelri |
| Novo Nordisk INC | $243.70 | 2021-2023 | |
| United Therapeutics Corporation | $243.70 | 2023 | |
| Resmed Corp | $182.95 | 2019-2025 | |
| Idorsia Pharmaceuticals US INC | $177.97 | 2023 | Quviviq |
| Abbvie INC. | $156.68 | 2021-2024 | Qulipta |
| Arbor Pharmaceuticals, INC. | $145.92 | 2019-2022 | |
| Lilly USA, LLC | $139.27 | 2025 | Zepbound |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.99 | 2019 | |
| Glaxosmithkline, LLC. | $122.54 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $103.84 | 2019 | |
| 3b Medical, INC. | $103.08 | 2023-2025 | Luna |
| Fisher & Paykel Healthcare INC | $87.90 | 2019-2025 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $79.96 | 2020-2023 | Belsomra |
| Baxter Healthcare | $77.33 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $58.87 | 2019 | |
| Eisai INC. | $32.95 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.73 | 2023 | Ofev |
| Genzyme Corporation | $24.39 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $16.77 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $15.49 | 2025 | |
| Allergan, INC. | $12.65 | 2019 | |
| Tanabe Pharma America, INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Viscomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.